IL113244A0 - Method of combating mammalian neoplasia and lytic peptides therefor - Google Patents

Method of combating mammalian neoplasia and lytic peptides therefor

Info

Publication number
IL113244A0
IL113244A0 IL11324495A IL11324495A IL113244A0 IL 113244 A0 IL113244 A0 IL 113244A0 IL 11324495 A IL11324495 A IL 11324495A IL 11324495 A IL11324495 A IL 11324495A IL 113244 A0 IL113244 A0 IL 113244A0
Authority
IL
Israel
Prior art keywords
combating
therefor
lytic peptides
mammalian neoplasia
neoplasia
Prior art date
Application number
IL11324495A
Other languages
English (en)
Original Assignee
Demeter Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Demeter Biotech Ltd filed Critical Demeter Biotech Ltd
Publication of IL113244A0 publication Critical patent/IL113244A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11324495A 1994-04-08 1995-04-04 Method of combating mammalian neoplasia and lytic peptides therefor IL113244A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22547694A 1994-04-08 1994-04-08

Publications (1)

Publication Number Publication Date
IL113244A0 true IL113244A0 (en) 1995-07-31

Family

ID=22845029

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11324495A IL113244A0 (en) 1994-04-08 1995-04-04 Method of combating mammalian neoplasia and lytic peptides therefor

Country Status (3)

Country Link
AU (1) AU2281595A (xx)
IL (1) IL113244A0 (xx)
WO (1) WO1995027497A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527775A (en) * 1994-10-13 1996-06-18 Enzon, Inc. Reduction of mammalian neoplasms with phospholipase A2 activating substances
US6042848A (en) * 1996-08-15 2000-03-28 The Board Of Trustees Of Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB0605685D0 (en) * 2006-03-21 2006-05-03 Lytix Biopharma As Inhibition of tumour growth
KR100438416B1 (ko) * 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
ATE189231T1 (de) * 1989-04-10 2000-02-15 Helix Biomedix Inc Lytische peptide, verwendung als wachstumsfördernde mittel und für infektionen und krebs

Also Published As

Publication number Publication date
WO1995027497A1 (en) 1995-10-19
AU2281595A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
PL326069A1 (en) Novel stable liquid paracetamol-based preparations and method of obtaining them
EP0785276A4 (en) MODIFICATION OF A PEPTIDE AND A PROTEIN
IL116458A0 (en) Aerosol formulations of peptides and proteins
PL330903A1 (en) Aqueous preparations of peptides
EP1011746A4 (en) IMPROVED ELECTRODES AND METHOD FOR THEIR USE
EP1037911A4 (en) ANTI-PATHOGEN SYSTEM AND METHOD FOR USE THEREOF
IL114331A0 (en) Medical use of bromelain
GB9507126D0 (en) Detection system and method of operating same
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
EP0681826A3 (en) Heat-proof hair treatment composition and its application.
HU9402361D0 (en) New makrolides and use of them
EP0702080A3 (en) Azeotropic compositions containing octamethyltrisiloxane and n-propoxypropanol
PL323138A1 (en) Pharmaceutic agent containing thiagabine chlorhydride and method of obtaining same
HU9700071D0 (en) Use of muramilpeptides
IL113992A0 (en) Use of copolymer-1
IL113244A0 (en) Method of combating mammalian neoplasia and lytic peptides therefor
ZA951485B (en) Medical application of bromelain
EP1007145A4 (en) BLOOD COLLECTION SYSTEM AND METHOD OF USING SAME
IL122175A0 (en) Autoclaves and method of operating them
PL318880A1 (en) Phenyl peptides, method of obtaining them and pharmaceutic preparations containing such peptides
PL303142A1 (en) Method of obtaining photosensibilising preparations
GB9318914D0 (en) Preparation of fluoro-nucleosides and intermediates for use therein
PL315474A1 (en) Method of obtaining peptides containing alpha-hydroxymethylserine
PL304046A1 (en) Anticarcinogenous preparation and method of obtaining same
HU9502356D0 (en) Detection of high risk factor to develop